Cargando…
Multisite Validation of Cryptococcal Antigen Lateral Flow Assay and Quantification by Laser Thermal Contrast
Cryptococcal meningitis is common in sub-Saharan Africa. Given the need for data for a rapid, point-of-care cryptococcal antigen (CRAG) lateral flow immunochromatographic assay (LFA), we assessed diagnostic performance of cerebrospinal fluid (CSF) culture, CRAG latex agglutination, India ink microsc...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884728/ https://www.ncbi.nlm.nih.gov/pubmed/24378231 http://dx.doi.org/10.3201/eid2001.130906 |
_version_ | 1782298636740198400 |
---|---|
author | Boulware, David R. Rolfes, Melissa A. Rajasingham, Radha von Hohenberg, Maximilian Qin, Zhenpeng Taseera, Kabanda Schutz, Charlotte Kwizera, Richard Butler, Elissa K. Meintjes, Graeme Muzoora, Conrad Bischof, John C. Meya, David B. |
author_facet | Boulware, David R. Rolfes, Melissa A. Rajasingham, Radha von Hohenberg, Maximilian Qin, Zhenpeng Taseera, Kabanda Schutz, Charlotte Kwizera, Richard Butler, Elissa K. Meintjes, Graeme Muzoora, Conrad Bischof, John C. Meya, David B. |
author_sort | Boulware, David R. |
collection | PubMed |
description | Cryptococcal meningitis is common in sub-Saharan Africa. Given the need for data for a rapid, point-of-care cryptococcal antigen (CRAG) lateral flow immunochromatographic assay (LFA), we assessed diagnostic performance of cerebrospinal fluid (CSF) culture, CRAG latex agglutination, India ink microscopy, and CRAG LFA for 832 HIV-infected persons with suspected meningitis during 2006–2009 (n = 299) in Uganda and during 2010–2012 (n = 533) in Uganda and South Africa. CRAG LFA had the best performance (sensitivity 99.3%, specificity 99.1%). Culture sensitivity was dependent on CSF volume (82.4% for 10 μL, 94.2% for 100 μL). CRAG latex agglutination test sensitivity (97.0%–97.8%) and specificity (85.9%–100%) varied between manufacturers. India ink microscopy was 86% sensitive. Laser thermal contrast had 92% accuracy (R = 0.91, p<0.001) in quantifying CRAG titers from 1 LFA strip to within <1.5 dilutions of actual CRAG titers. CRAG LFA is a major advance for meningitis diagnostics in resource-limited settings. |
format | Online Article Text |
id | pubmed-3884728 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-38847282014-01-08 Multisite Validation of Cryptococcal Antigen Lateral Flow Assay and Quantification by Laser Thermal Contrast Boulware, David R. Rolfes, Melissa A. Rajasingham, Radha von Hohenberg, Maximilian Qin, Zhenpeng Taseera, Kabanda Schutz, Charlotte Kwizera, Richard Butler, Elissa K. Meintjes, Graeme Muzoora, Conrad Bischof, John C. Meya, David B. Emerg Infect Dis Research Cryptococcal meningitis is common in sub-Saharan Africa. Given the need for data for a rapid, point-of-care cryptococcal antigen (CRAG) lateral flow immunochromatographic assay (LFA), we assessed diagnostic performance of cerebrospinal fluid (CSF) culture, CRAG latex agglutination, India ink microscopy, and CRAG LFA for 832 HIV-infected persons with suspected meningitis during 2006–2009 (n = 299) in Uganda and during 2010–2012 (n = 533) in Uganda and South Africa. CRAG LFA had the best performance (sensitivity 99.3%, specificity 99.1%). Culture sensitivity was dependent on CSF volume (82.4% for 10 μL, 94.2% for 100 μL). CRAG latex agglutination test sensitivity (97.0%–97.8%) and specificity (85.9%–100%) varied between manufacturers. India ink microscopy was 86% sensitive. Laser thermal contrast had 92% accuracy (R = 0.91, p<0.001) in quantifying CRAG titers from 1 LFA strip to within <1.5 dilutions of actual CRAG titers. CRAG LFA is a major advance for meningitis diagnostics in resource-limited settings. Centers for Disease Control and Prevention 2014-01 /pmc/articles/PMC3884728/ /pubmed/24378231 http://dx.doi.org/10.3201/eid2001.130906 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Boulware, David R. Rolfes, Melissa A. Rajasingham, Radha von Hohenberg, Maximilian Qin, Zhenpeng Taseera, Kabanda Schutz, Charlotte Kwizera, Richard Butler, Elissa K. Meintjes, Graeme Muzoora, Conrad Bischof, John C. Meya, David B. Multisite Validation of Cryptococcal Antigen Lateral Flow Assay and Quantification by Laser Thermal Contrast |
title | Multisite Validation of Cryptococcal Antigen Lateral Flow Assay and Quantification by Laser Thermal Contrast |
title_full | Multisite Validation of Cryptococcal Antigen Lateral Flow Assay and Quantification by Laser Thermal Contrast |
title_fullStr | Multisite Validation of Cryptococcal Antigen Lateral Flow Assay and Quantification by Laser Thermal Contrast |
title_full_unstemmed | Multisite Validation of Cryptococcal Antigen Lateral Flow Assay and Quantification by Laser Thermal Contrast |
title_short | Multisite Validation of Cryptococcal Antigen Lateral Flow Assay and Quantification by Laser Thermal Contrast |
title_sort | multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884728/ https://www.ncbi.nlm.nih.gov/pubmed/24378231 http://dx.doi.org/10.3201/eid2001.130906 |
work_keys_str_mv | AT boulwaredavidr multisitevalidationofcryptococcalantigenlateralflowassayandquantificationbylaserthermalcontrast AT rolfesmelissaa multisitevalidationofcryptococcalantigenlateralflowassayandquantificationbylaserthermalcontrast AT rajasinghamradha multisitevalidationofcryptococcalantigenlateralflowassayandquantificationbylaserthermalcontrast AT vonhohenbergmaximilian multisitevalidationofcryptococcalantigenlateralflowassayandquantificationbylaserthermalcontrast AT qinzhenpeng multisitevalidationofcryptococcalantigenlateralflowassayandquantificationbylaserthermalcontrast AT taseerakabanda multisitevalidationofcryptococcalantigenlateralflowassayandquantificationbylaserthermalcontrast AT schutzcharlotte multisitevalidationofcryptococcalantigenlateralflowassayandquantificationbylaserthermalcontrast AT kwizerarichard multisitevalidationofcryptococcalantigenlateralflowassayandquantificationbylaserthermalcontrast AT butlerelissak multisitevalidationofcryptococcalantigenlateralflowassayandquantificationbylaserthermalcontrast AT meintjesgraeme multisitevalidationofcryptococcalantigenlateralflowassayandquantificationbylaserthermalcontrast AT muzooraconrad multisitevalidationofcryptococcalantigenlateralflowassayandquantificationbylaserthermalcontrast AT bischofjohnc multisitevalidationofcryptococcalantigenlateralflowassayandquantificationbylaserthermalcontrast AT meyadavidb multisitevalidationofcryptococcalantigenlateralflowassayandquantificationbylaserthermalcontrast |